Citigroup
CORV

Citigroup’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Citigroup’s Portfolio CORV Stock Details CORV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-10
Closed – – 7928
2015
Q4 		$0 Sell
10
-10
-50% -$83 ﹤0.01% 8014
2015
Q3 		$0 Buy
+20
New +$184 ﹤0.01% 7928
2015
Q2 		– Sell
-1,298
Closed -$12K – 7881
2015
Q1 		$12K Buy
+1,298
New +$12.4K ﹤0.01% 6392
2014
Q3 		– Sell
-185
Closed -$1K – 7410
2014
Q2 		$1K Buy
+185
New +$1.4K ﹤0.01% 7001
2014
Q1 		– Sell
-167
Closed -$1K – 7292
2013
Q4 		$1K Buy
+167
New +$876 ﹤0.01% 6899

Other funds holding CORV

Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
CCP
Clough Capital Partners Boston, Massachusetts $1.23B AUM 51.32% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
AIS
AlphaOne Investment Services West Chester, Pennsylvania $79.5M AUM 49.42% 1-Year Est. Return
TI
Turner Investments Berwyn, Pennsylvania $134K AUM 49.03% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Citigroup's CORV Position: Q1 2016 in Review

Citigroup sold out of Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q1 2016, closing a stake of 10 shares.

Citigroup first reported a position in CORV in Q4 2013 and held it in 5 quarters. The position peaked at $12K in Q1 2015. 26 funds tracked by Wall St. Rank hold CORV as of Q1 2016.

  • Citigroup reported no remaining Correvio Pharma Corp. Ordinary Shares (Canada) position as of Q1 2016 after selling out during the quarter.
  • Citigroup sold 10 Correvio Pharma Corp. Ordinary Shares (Canada) shares in Q1 2016.
  • Citigroup first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q4 2013 and held it in 5 quarters.
  • Citigroup's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $12K in Q1 2015.
  • 26 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q1 2016.

Based on Citigroup's 13F filing for Q1 2016, filed 13 May 2016.